Hello Health Rounds readers! Today we ​highlight a potentially game-changing experimental contrast agent for MRI exams that may enable detection of lung cancer when tumors are ‌small and more ...

AI-assisted spirometry, imaging biomarkers, and population screening strategies highlighted early detection and prevention as a throughline at the ERS Congress. Artificial intelligence–supported ...

Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.

Cytological tests are a common method of screening for cancer cells in stained cell samples. Using a microscope, pathologists examine cells collected from bodily fluids, looking for telltale signs of ...

The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.

Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of ...

Mobile low-dose computed tomography (LDCT) screening can reach high-risk and socially vulnerable populations in ...

A single blood test that can identify most cancers remains the aspirational goal of cancer screening. The US biotechnology company Grail has been closest to developing a viable multicancer detection ...

A little-known chronic lung disease is silently emerging as a growing public health threat in the U.S. and around the world.

Altis Labs, Inc. ("Altis"), the AI endpoint company accelerating clinical trials, today announced findings from an independent post-hoc analysis evaluating its AI-powered imaging endpoint, IPRO, in ...

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a ...

A novel collagen-targeted MRI contrast agent detects lung cancer and metastases with greater sensitivity than traditional ...